Insilica expands its ToxIndex platform through a partnership with ProtoQSAR, adding 60 ProtoPRED models to enhance the speed and transparency of in-silico toxicology assessments for global markets.
Insilica partners with ProtoQSAR to expand ToxIndex with over 60 ProtoPRED models, enhancing its in-silico assessment capabilities.
ProtoQSAR integrates its ProtoPRED models into ToxIndex, expanding its market reach and validating its predictive toxicology solutions.
Insilica has entered a strategic partnership with ProtoQSAR to bolster its ToxIndex platform. By integrating over 60 ProtoPRED predictive models, the company aims to accelerate in-silico assessment workflows, providing clients with more transparent and efficient toxicology screening tools.
The partnership aims to enhance the ToxIndex platform by integrating ProtoQSAR's ProtoPRED models, ultimately making in-silico toxicology assessments faster and more transparent.